We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

2 hedge funds and large institutions have $66 invested in Accentia Biopharmaceuticals in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

51% less capital invested

Capital invested by funds: $135 → $66 (-$69)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$66 – – –

ABPI Hedge Fund Activity: Q2 2014 in Review

2 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q2 2014, worth a combined $66 — down 51% from $135 a quarter earlier.

Fund positioning in ABPI was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $66 of Accentia Biopharmaceuticals stock for Q2 2014, down 51% quarter-over-quarter.
  • 0 funds opened new Accentia Biopharmaceuticals positions in Q2 2014 and 0 closed out.

Based on aggregated 13F filings for Q2 2014.